Cyclacel Pharmaceuticals to Release Second Quarter 2021 Financial Results and Provide Business Update

NEXT STORY
Rhythm Pharmaceuticals Reports Second Quarter 2021 Financial Results
PREV STORY
Rhythm Pharmaceuticals Announces Comprehensive Expansion of Clinical Development Program with Five New Phase 2 and 3 Trials Planned to Evaluate Setmelanotide in Rare Genetic Diseases of Obesity
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sun BioPharma, Inc. Provides a Business Update and Files Report for Q1 2019

author_avatar
NASDAQ Market News

The rapid diagnostics market by revenue is expected to grow at a CAGR of 10% during the period 2019–2025

author_avatar
NASDAQ Market News

Surface Oncology Named a 2021 Best Places to Work Company by Boston Business Journal

author_avatar
NASDAQ Market News